Abstract | BACKGROUND AND PURPOSE: METHODS: Thirty two patients who met the diagnostic criteria for HSP were included. They were divided into two groups - HSP patients with thrombocytosis (n = 14) and those without thrombocytosis (n = 18) with a platelet count of 400,000/microL. Eight normal healthy controls were also included. TPO and IL-6 serum levels during the acute phase were measured by enzyme-linked immunosorbent assay. RESULTS: Patients with platelet counts greater than 400,000/microL in the acute stage had significantly lower TPO levels than patients with platelet counts lower than 400,000/microL (310 +/- 65.6 pg/mL vs 608 +/- 97.8 pg/mL, p=0.013). However, HSP patients with or without thrombocytosis had similar TPO levels as the healthy controls (441 +/- 176 pg/mL, p=0.89 and 0.29, respectively). IL-6 serum levels were significantly elevated in HSP patients during the acute stage of HSP (28.6 +/- 61.7 pg/mL vs 3.16 +/- 1.35 pg/mL, p=0.049). In patients with complications of glomerulonephritis or gastrointestinal hemorrhage (n = 12), IL-6 levels were significantly lower than in those without such complications (8.07 +/- 3.79 pg/mL vs 40.9 +/- 16.9 pg/mL, p=0.007). CONCLUSIONS: This study showed that thrombocytosis in HSP patients is a type of inflammatory reactive thrombocytosis, and that IL-6 may also play a role in the pathogenesis of HSP.
|
Authors | Chih-Yang Lin, Yao-Hsu Yang, Chien-Chang Lee, Chou-Lang Huang, Li-Chieh Wang, Bor-Luen Chiang |
Journal | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
(J Microbiol Immunol Infect)
Vol. 39
Issue 6
Pg. 476-82
(Dec 2006)
ISSN: 1684-1182 [Print] England |
PMID | 17164950
(Publication Type: Journal Article)
|
Chemical References |
- Interleukin-6
- Thrombopoietin
|
Topics |
- Child
- Child, Preschool
- Female
- Hospitals, Teaching
- Humans
- IgA Vasculitis
(blood, complications, physiopathology)
- Infant
- Interleukin-6
(blood)
- Male
- Platelet Count
- Taiwan
- Thrombocytosis
(etiology)
- Thrombopoietin
(blood)
|